Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Whole grains, legumes and vegetables stand out in a major review of diabetes diets

Healthy plant-based diets rich in whole grains, legumes, fruits, vegetables, nuts, and seeds are associated with better glycemic control and a lower risk of type 2 diabetes. The review finds that food quality and processing matter more than simply avoiding animal foods, while unhealthy plant-based patterns and higher red and processed meat intake are associated with greater metabolic risk.

18 Aug 2026

Why keto appears to lower blood pressure for some people but not others

A narrative review finds that ketogenic diets may modestly lower blood pressure through weight loss, reduced visceral fat, improved insulin sensitivity, fluid and electrolyte shifts, and anti-inflammatory effects. However, effects vary across studies, long-term cardiovascular evidence remains limited, and diet quality, hydration, electrolyte balance, and medication monitoring are important.

17 Aug 2026

Cocoa looks promising for mood, but the brain benefits come with a catch

A review of clinical and preclinical studies suggests cocoa polyphenols may support mood, neuroplasticity, cerebral blood flow, and gut-brain signaling through pathways involving BDNF/CREB, inflammation, and oxidative stress.

17 Aug 2026

What 720,000 adults reveal about artificial sweeteners and diabetes risk

A meta-analysis of six prospective cohort studies involving 721,003 adults found that higher artificial sweetener intake was associated with a 31% greater risk of developing type 2 diabetes. The evidence was rated low certainty because of substantial heterogeneity, observational study designs, and potential residual confounding, meaning the findings do not establish causation.

16 Aug 2026

Sprint exercise sends a very different molecular signal through the body

Sprint-interval exercise triggers a much larger and faster shift in circulating proteins and metabolites than moderate-intensity exercise, revealing distinct patterns of predicted communication between organs. The findings suggest that exercise intensity shapes systemic molecular signaling, with skeletal muscle and adipose tissue emerging as potential source and target tissues linked to cardiometabolic health.

16 Aug 2026

Self-guided online compassion therapy may improve quality of life in chronic illness

A fully self-guided, internet-delivered attachment-based compassion therapy improved overall quality of life and reduced preoccupied attachment compared with a waiting-list control in adults with chronic medical conditions. The findings are preliminary, with high attrition, no active control, and most secondary psychological outcomes showing no significant between-group differences.

16 Aug 2026

Three minutes of sprinting dramatically reshape molecular contents of the bloodstream

Three minutes of sprinting can do something that 90 minutes of moderate exercise apparently cannot: dramatically reshape the molecular contents of the bloodstream.

14 Aug 2026

Finnish study links habitual coffee consumption to healthier body metabolism

Coffee is one of the world's most widely consumed beverages, and previous research has linked its consumption to a lower risk of conditions such as type 2 diabetes and cardiovascular disease.

13 Aug 2026

$Bone loss alone fails to explain diabetes-related fracture risk$

Bone loss alone fails to explain diabetes-related fracture risk

A new study published in Diabetes Care finds that bone loss alone does not explain the increased fracture risk observed in some older adults with type 2 diabetes.

11 Aug 2026

Semaglutide slows blood protein signature linked to future dementia risk

A post hoc analysis of 2,970 older SELECT participants found that semaglutide slowed worsening of a 25-protein blood signature that predicts future dementia risk. Over 104 weeks, semaglutide produced larger effects on modeled 5-year than 20-year dementia risk, but whether these biomarker changes translate into less cognitive decline or dementia remains unknown.

10 Aug 2026

Tirzepatide lowers heart attack and cardiovascular event risk in adults with type 2 diabetes

In a US cohort of 52,971 adults with type 2 diabetes and established atherosclerotic cardiovascular disease, tirzepatide initiation was associated with a lower one-year risk of major adverse cardiovascular events than sitagliptin. The benefit was driven mainly by lower myocardial infarction and all-cause mortality hazards, although the authors cautioned that mortality findings may be influenced by residual confounding.

10 Aug 2026

Thinning cancer cells' sugar coating could expose tumors to immune attack

Like spies evading detection through being masters of disguise, many cancer cells are adorned with a copious coat of sugar-derived molecules that throws the proverbial hounds of our immune systems off the scent.

7 Aug 2026

Genetic analysis of 1 million people points to FNIP1 as a promising metabolic target

Mega-scale exome sequencing of 1,032,116 people identified 59 independent genes linked to the TG:HDL ratio, including 44 rare-coding associations not detected in the previous largest analysis. Ultra-rare FNIP1 loss-of-function variants were associated with favorable fat distribution, lower liver fat and glycemia, and around 60% lower odds of a composite cardiometabolic disease outcome.

7 Aug 2026

Swiss flagship project harnesses AI and sensors for diabetes prevention

Type 2 diabetes generates high healthcare costs in Switzerland and causes significant suffering for those affected.

6 Aug 2026

New research highlights hidden metabolic risks in non-obese HIV patients

A new UC San Francisco study helps explain why people with HIV remain at elevated risk for type 2 diabetes despite effective suppression of the virus with modern medications.

6 Aug 2026

GLP-1 drug tirzepatide associated with lower risk of major cardiovascular events

Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart attack or stroke, finds a study published by The BMJ today.

5 Aug 2026

Type 2 diabetes linked to more severe menopause symptoms

The type of menopause symptoms, as well as their severity, can differ greatly among women. A number of earlier studies have suggested various reasons for those differences.

5 Aug 2026

$GLP-1 therapy may help reduce fracture risk among adults with type 2 diabetes$

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Whole grains, legumes and vegetables stand out in a major review of diabetes diets

Why keto appears to lower blood pressure for some people but not others

Cocoa looks promising for mood, but the brain benefits come with a catch

What 720,000 adults reveal about artificial sweeteners and diabetes risk

Sprint exercise sends a very different molecular signal through the body

Self-guided online compassion therapy may improve quality of life in chronic illness

Three minutes of sprinting dramatically reshape molecular contents of the bloodstream

Finnish study links habitual coffee consumption to healthier body metabolism

Bone loss alone fails to explain diabetes-related fracture risk

Semaglutide slows blood protein signature linked to future dementia risk

Tirzepatide lowers heart attack and cardiovascular event risk in adults with type 2 diabetes

Thinning cancer cells' sugar coating could expose tumors to immune attack

Genetic analysis of 1 million people points to FNIP1 as a promising metabolic target

Swiss flagship project harnesses AI and sensors for diabetes prevention

New research highlights hidden metabolic risks in non-obese HIV patients

GLP-1 drug tirzepatide associated with lower risk of major cardiovascular events

Type 2 diabetes linked to more severe menopause symptoms

GLP-1 therapy may help reduce fracture risk among adults with type 2 diabetes

Exercise helps protect Hispanic adults from late life cognitive decline

Researchers suggest a potential therapeutic strategy for muscle loss associated with obesity

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Newsletters you may be interested in